ljhf;h?e:klhf?ljb3:b multiplate :=j?=hf?ljb3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... ·...
TRANSCRIPT
![Page 1: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/1.jpg)
Н Ј У
Ј , . Ј
Д ц ј 30.05.2014
ц
- Ј - Ј ,
.
Н ц ј
- Њ ј , , . ј (18-28. 02. 2014 )
Ј MULTIPLATE Ј
![Page 2: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/2.jpg)
![Page 3: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/3.jpg)
ј 1: ј EXTEM INTEM.
APTEM , .
![Page 4: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/4.jpg)
ј aprotinin ( ). (MCF),
њ (CFT) – ј .
![Page 5: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/5.jpg)
ј , њ .
![Page 6: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/6.jpg)
ј 2: ROTEM ј ј ј
• , 4
• : PT – Quick 40%; aPTT 55,8 s; Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL
• : Fg;
; AT-III; ј ;
DD – ?
• ј : 3 g ; 4000 IE ;
3000 IE AT-III
![Page 7: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/7.jpg)
![Page 8: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/8.jpg)
њ ј ј :
• њ њ ј
• ј ј , њ ј EXTEM INTEM
. ј : њ ;
ј ј ј ROTEM: aspirin,
von Willebrand – , warfarin
• EXTEM APTEM њ ; FIBTEM
• HEPTEM CT INTEM
• ј Clinic Cologne - Merheim
![Page 9: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/9.jpg)
![Page 10: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/10.jpg)
![Page 11: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/11.jpg)
![Page 12: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/12.jpg)
![Page 13: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/13.jpg)
![Page 14: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/14.jpg)
њ ј Multiplate
• њ ( )
• ј
• Multiplate 20% ј
clopidogrel
![Page 15: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/15.jpg)
• ј Clopidogrel spirin њ
• Multiplate њ ј spirin,
Clopidogrel, Prasugrel, IIb IIIa
• ј њ
• : ј , ј , ј ,
ј ,
![Page 16: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/16.jpg)
/
• ROTEM њ 5 – 10
• њ ј ; њ
ј ; ј ј ј
• ROTEM ј ј : ,
, , ,
,
• њ њ њ
• ѓ ј , ј , ј , ј ,
![Page 17: LJHF;H?E:KLHF?LJB3:B MULTIPLATE :=J?=HF?LJB3: …zdravstvo.gov.mk/wp-content/uploads/2015/12/... · Fg 0,87 g/L; AT-III 49%; DD 39,7; Plt 101 000/ µL Ijhp_gdZ gZfZe_ghgb\hgZ Fg;](https://reader034.vdocuments.net/reader034/viewer/2022050222/5f6750c7fdf026718b110eeb/html5/thumbnails/17.jpg)
/
• Multiplate ј
• њ ј
•
• 5 њ
• , ,